Olympus Partners Acquires PAI Pharma

PAI Pharma Acquires Nivagen Pharmaceuticals

January 8, 2026

Pharmaceuticals

PAI Pharma, an Olympus Partners portfolio company, has acquired Nivagen Pharmaceuticals to add a newly built aseptic sterile-injectable manufacturing facility in Sacramento, California and a pipeline of more than 20 ready-to-use (RTU) injectable products. The add-on expands PAI's sterile injectable capabilities alongside its oral liquid franchise to better serve hospitals and health systems and strengthen U.S. pharmaceutical supply-chain resilience; financial terms were not disclosed.

PAI Partners to Acquire SGD Pharma from China Jianyin Investment (JIC)

June 16, 2021

Packaging

PAI Partners has made a binding offer to acquire SGD Pharma, a global manufacturer of primary glass packaging for the pharmaceutical industry, from China Jianyin Investment Ltd. (JIC). The contemplated buyout, subject to employee consultations, Ministry of Finance of China approvals and antitrust clearance, aims to accelerate SGD Pharma’s growth through organic investment and external initiatives.

SAI MedPartners Acquires IDEA Pharma

November 14, 2024

Healthcare Services

SAI MedPartners, a global life-sciences consultancy backed by Northlane Capital Partners, has acquired London-headquartered IDEA Pharma to strengthen its pharmaceutical path-to-market, clinical development, and commercialization capabilities. The acquisition is an add-on to SAI's platform, expanding its strategic services offering to biopharma and medical device clients.

ON Partners Acquires Olympus Search Partners

February 23, 2023

Professional Services

ON Partners has acquired boutique retained search firm Olympus Search Partners and appointed its founder and managing partner Ashley Estes as a senior partner. The acquisition strengthens ON Partners' healthcare and TMT capabilities and expands its coverage with Estes splitting time between San Diego (La Jolla) and Madrid.

PAI Partners Acquires Majority Stake in Nutripure

July 25, 2024

Consumer Products

PAI Partners, through its PAI Mid-Market Fund, has agreed to acquire a majority, controlling stake in Nutripure from Ardian. The investment will support Nutripure’s product development, community growth and European expansion while founders and Bpifrance remain shareholders.

SAI MedPartners Acquires PharmaForce International

March 29, 2023

Healthcare Services

SAI MedPartners, a consultancy focused on strategic insights and analytics for the pharmaceutical, biotech, and medical device industries, has acquired PharmaForce International, a Reading, Pennsylvania–based market intelligence and syndicated research firm. The acquisition adds PharmaForce's commercial benchmarking and syndicated research capabilities to SAI's competitive intelligence offerings; SAI is PE-backed by Northlane Capital Partners (which partnered with management to acquire SAI in June 2022).